Literature DB >> 24016689

Treatment and course of different subtypes of status epilepticus.

Kristin Rantsch1, Uwe Walter, Matthias Wittstock, Reiner Benecke, Johannes Rösche.   

Abstract

Since randomized controlled trials are difficult to perform for ethical reasons in a potentially deadly condition like status epilepticus (SE), a retrospective database analysis may be welcome to broaden the evidence for the treatment of SE. In this retrospective study we evaluated every SE treatment at the neurological department of the University of Rostock from January 2000 to December 2009 in order to determine the efficacy of different antiepileptic drugs (AEDs) in terminating different kinds of SE. We analyzed the frequency of refractory courses in different types of SE, at which time which AED was administered and at which time which AED was effective to terminate the different epileptic conditions. A second aim of this study was to evaluate the course and the outcome of different kinds of SE. Statistical comparisons were performed with the χ(2)-test. 167 episodes of SE in 118 patients could be evaluated. The efficacy rates of AEDs differed significantly, mainly due to the superior efficacy of clonazepam (CZP). CZP seemed to be more effective than DZP, LEV, MDM and VPA in terminating generalized convulsive status epilepticus (GCSE), whereas there was no significant difference in the efficacy for terminating nonconvulsive status epilepticus (NCSE) and epilepsia partialis continua (EPC) between the used AEDs. Anaesthesia and CZP both terminated GCSE more effectively than NCSE and EPC. Concerning the course of the different kinds of SE the following results were obtained: 13 patients died during hospital treatment. Treatment in NCSE and EPC started significantly later than in GCSE. There was no significant difference in mortality between the types of SE. However the frequency of refractory courses differed between the types of SE. At the time of SE termination without the administration of anaesthesia a combination therapy using 2 or more AEDs was established in most episodes.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clonazepam; Combination therapy; Outcome criteria; Refractory status epilepticus; Treatment delay

Mesh:

Substances:

Year:  2013        PMID: 24016689     DOI: 10.1016/j.eplepsyres.2013.08.001

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

1.  [Can treatment with anesthetic anticonvulsive drugs worsen outcome in status epilepticus?]

Authors:  J Rösche; K Kupper; M Wittstock; U Walter
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-03-01       Impact factor: 0.840

2.  Treatment of Convulsive Status Epilepticus.

Authors:  Eric H Grover; Yara Nazzal; Lawrence J Hirsch
Journal:  Curr Treat Options Neurol       Date:  2016-03       Impact factor: 3.598

3.  Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison.

Authors:  Vincent Alvarez; Jong Woo Lee; Frank W Drislane; M Brandon Westover; Jan Novy; Barbara A Dworetzky; Andrea O Rossetti
Journal:  Epilepsia       Date:  2015-07-03       Impact factor: 5.864

Review 4.  Timing is everything: Where status epilepticus treatment fails.

Authors:  Chloe E Hill; Alomi O Parikh; Colin Ellis; Jennifer S Myers; Brian Litt
Journal:  Ann Neurol       Date:  2017-07-29       Impact factor: 10.422

5.  Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.

Authors:  David G Vossler; Jacquelyn L Bainbridge; Jane G Boggs; Edward J Novotny; Tobias Loddenkemper; Edward Faught; Marta Amengual-Gual; Sarah N Fischer; David S Gloss; Donald M Olson; Alan R Towne; Dean Naritoku; Timothy E Welty
Journal:  Epilepsy Curr       Date:  2020-08-21       Impact factor: 7.500

6.  Timing matters: there are significant differences in short-term outcomes between two time points of status epilepticus.

Authors:  Yiwen Pan; Yu Feng; Weifeng Peng; Yang Cai; Jing Ding; Xin Wang
Journal:  BMC Neurol       Date:  2022-09-14       Impact factor: 2.903

Review 7.  Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability.

Authors:  Adam Strzelczyk; Laurent M Willems; Ricardo Kienitz; Lara Kay; Isabelle Beuchat; Sarah Gelhard; Sophie von Brauchitsch; Catrin Mann; Alexandra Lucaciu; Jan-Hendrik Schäfer; Kai Siebenbrodt; Johann-Philipp Zöllner; Susanne Schubert-Bast; Felix Rosenow
Journal:  CNS Drugs       Date:  2022-08-16       Impact factor: 6.497

8.  Delays and Factors Related to Cessation of Generalized Convulsive Status Epilepticus.

Authors:  Leena Kämppi; Jaakko Ritvanen; Harri Mustonen; Seppo Soinila
Journal:  Epilepsy Res Treat       Date:  2015-08-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.